Tervisetehnoloogiate Arenduskeskus AS (The Competence Centre on Health Technologies, CCHT) is a biotechnology company focused on research and product development in personal medicine, drug development and both human and veterinary reproductive medicine. We collaborate closely with leading Estonian scientists, universities and biotechnology companies as well as scientific, medical and R&D institutions from Europe, Asia and America.

PGS - Preimplantation genetic screening

Preimplantation genetic screening is a genetic analysis that evaluates embryo chromosome number prior to transfer in an IVF cycle.

READ MORE

NIPT - Non-invasive prenatal testing

Non-invasive prenatal testing is the newest and the most sensitive screening method for identifying fetal genetic diseases already in the first month of pregnancy.

READ MORE

FERTIFY®

New evidence-based personalised medicine tool FERTIFY® for predicting female fertility and age-related infertility risk.

READ MORE

News

Dr. Velthut-Meikas talked at ESHRE 2018 Barcelona

Recent findings of a comprehensive two centre RNA-seq study were…

Read more ❯❯

CCHT’s new genomic pipeline for NIPT

Recent publication of Scientific Reports  introduced CCHT’s new genomic pipeline…

Read more ❯❯

Postimees: Triin Laisk, a researcher at Tervisetehnoloogiate Arenduskeskus AS has focused on increasing the awareness on female fertility

28.03.2017 Postimees: Triin Laisk, a researcher at Tervisetehnoloogiate Arenduskeskus AS…

Read more ❯❯

Partners